How has been the historical performance of Gian Lifecare?

Answer:The historical performance of Gian Lifecare shows a mixed trend over the past three fiscal years.

Breakdown:
In the fiscal year ending March 2024, Gian Lifecare reported net sales of 13.12 Cr, an increase from 11.92 Cr in March 2023, but a decline from 15.93 Cr in March 2022. The total operating income mirrored this trend, remaining at 13.12 Cr in March 2024, compared to 11.92 Cr in the previous year and 15.93 Cr two years prior. Total expenditure decreased significantly to 7.05 Cr in March 2024 from 10.10 Cr in March 2023, leading to an operating profit (PBDIT) of 6.74 Cr, which was a substantial improvement from 2.51 Cr in March 2023 and close to the 6.54 Cr recorded in March 2022. Profit before tax also rose to 5.75 Cr in March 2024 from 1.59 Cr in the previous year, while profit after tax increased to 4.15 Cr from 1.06 Cr. However, this was slightly lower than the 4.37 Cr reported in March 2022. The earnings per share (EPS) for March 2024 stood at 4.01, a significant rise from 1.03 in March 2023, but a slight decrease from 4.23 in March 2022. The operating profit margin improved to 46.27% in March 2024, up from 15.27% in March 2023, while the profit after tax margin also saw a notable increase to 31.63%. Cash flow from operating activities was reported at 0.00 Cr for March 2024, down from 2.00 Cr in March 2023, with closing cash and cash equivalents remaining stable at 5.00 Cr. Overall, Gian Lifecare's performance reflects fluctuations in sales and profits, with significant improvements in margins and a stable cash position.